(PharmaNewsWire.Com, October 18, 2019 ) The rat models are being used in many applications such as toxicology, oncology, diabetes, neurology, immunology and infectious diseases, and others (rare disease, cardiovascular, metabolic disease, hematopoiesis, and regenerative medicines).
What the Market Looks Like?
Predicted to grow at a CAGR of 8.7% during the forecast period, the global Rat Model Market is estimated to reach USD 588.9 Million by the end of 2021. In 2016, the CRISPR segment is expected to command the largest share of the global market.
On the basis of type, the Rat Model Market is segmented into outbred rats, inbred rats, knockout/genetically engineered rats, hybrid/congenic rats, conditioned/surgically modified rats, and immunodeficient rat’s model. Knockout/genetically engineered rat’s segment is expected to grow at the highest CAGR during the forecast period.
On the basis of services, the Rat Model Market is segmented into breeding, cryopreservation, quarantine, rederivation, model in-licensing, genetic testing, and others such as surgical services, line rescue services, and in vivo pharmacology services.
On the basis of technology, the Rat Model Market is segmented into CRISPR, microinjection, embryonic stem cell injection, nuclear transfer technology, and others (genetically modified sperm-mediated gene transfer, Virus/vector-mediated gene transfer, Liposome-Mediated DNA Transfers, Electroporation of DNA, Biolistics, and TALENs & ZFN).
The growth of the global market for Rat Model is primarily influenced by the following factors:
• Advancements in Gene Editing Tools Set to Augment the Demand for Rat Models • Advantages Offered by Rats Over Mice • Continuous Support in the Form of Investments and Grants • Increased Demand for Personalized Humanized Rat Models Due to Growing Consumption of Personalized Medicines • Increase in R&D Activities Carried Out by Pharmaceutical and Biotechnology Companies
DIABETES:
Rats are excellent experimental models for understanding the complex genetic basis of diseases such as diabetes. Due to the ever-increasing prevalence of diabetes globally; it has become important to study the mechanism of the disease. However, it is quite difficult to carry out research studies in human beings, owing to problems such as genetic heterogeneity and lack of controlled lifestyles. Rat models act as suitable models to study specific genetic mutations and to understand the function of genes on a homogeneous genetic background.
North America Europe Asia-Pacific Rest of the World
Leading market players and strategies adopted:
The prominent players in the Rat Model Market include Charles River Laboratories International (US), Envigo (UK), and Taconic Biosciences (US). Other players include Horizon Discovery Group (UK), genOway (France), Laboratory Corporation of America Holdings (US), Transposagen Biopharmaceuticals (US), Transviragen (US), Janvier Labs (France), and Biomere (US).
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
